Helix Biopharma Corp fka HBPCF

[mlkrborn]

Helix BioPharma Corp. Announces Appointment of Special Committee
MarketwirePress Release: Helix BioPharma Corp. – 14 hours ago

Companies:

* Helix BioPharma Corp.
* HELIX BIOPHARMA
* Helix Biopharma Corp.

RELATED QUOTES
Symbol Price Change
HBP.TO 1.86 +0.16

AURORA, ON--(Marketwire -11/16/11)- Helix BioPharma Corp. (TSX: HBP.TO - News) (AMEX: HBP.TO - News) (Frankfurt: HBP.TO - News) ("HBP" or "the Company") announces that its Board of Directors (the "Board") appointed a special committee of independent directors (the "Special Committee") to advise the Board with respect to the Company's annual general meeting of shareholders to be held on January 30, 2012 (the "Meeting"). The members of the Special Committee are Jack M. Kay and W. Thomas Hodgson. The Special Committee is being advised by Norton Rose OR LLP.

The Special Committee will be dealing with matters recently raised by certain shareholders who participated in private placements by the Company in Europe. In this regard, a number of issues relating to the activities of third parties and their compliance with applicable laws have come to the attention of the Company's management and Board of Directors and have been referred to the Special Committee for further investigations.

Separately, the Company has retained Kingsdale Shareholder Services Inc. to assist with solicitation matters for the upcoming Meeting. A management information circular will be distributed to shareholders in advance of the Meeting.